Citation: | REN T, LI J, WANG L. A Nomogram for Predicting the Severity of COPD Based on CT Voxel Morphometrimetry[J]. CT Theory and Applications, xxxx, x(x): 1-7. DOI: 10.15953/j.ctta.2024.089. (in Chinese). |
Objective: In order to explore the quantitative indicators based on CT voxel, analyze the risk factors related to the severity of chronic obstructive pulmonary disease (COPD), and establish an individualized nomogram model for predicting severe COPD. >Methods: From May 2020 to September 2021, a total of 118 eligible COPD patients were enrolled in the Affiliated Hospital of Yan’an University after dual gas phase scanning and pulmonary function tests. According to the severity classification of COPD (GOLD) (group), the patients were divided into mild COPD group (GOLDI, grade II): 66 cases; Severe COPD group (GOLD III, IV): 52 cases. The quantitative and clinical indexes of dual-gas phase registration CT between mild and severe COPD groups were compared. SPSS and R software were used for statistical analysis, and a nomogram model was established to analyze the independent risk factors of severe COPD. Results: The percentage of functional small-airway disease area (fSAD%) and the that of emphysema area (Emph%) in the severe COPD group were higher than those in the mild COPD group. With the increase of COPD severity, the pulmonary function indexes FVC, FEV1%pred, and FEV1/FVC% decreased. The smoking index, fSAD%, and Emph% of the severe COPD group were higher than those of the mild COPD group. Through analysis, it was found that the smoking index and CT quantitative indicators (fSAD%, Empire%, and Normal%) are independent risk factors for severe COPD. Furthermore, a risk model for predicting severe COPD was established. CT quantitative indicators have a relatively greater impact on the weight of patient mortality risk than smoking index. The column chart prediction model was internally validated through a calibration chart, which showed that the model calibration curve was close to the standard curve. Conclusion: Quantitative indicators based on CT voxels can predict the severity of COPD. The established column chart model for predicting COPD severity through CT quantitative indicators and smoking index has good diagnostic efficacy.
[1] |
WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717. DOI: 10.1016/S0140-6736(18)30841-9.
|
[2] |
World Health Organization. Projections of mortality and causes of death, 2016 and 2060, online information available here http://www.who.int/healthinfo/global burden disease/projections/en/ [accessed Oct 2020].
|
[3] |
NEDER JA, DE-TORRES JP, MILNE KM, et al. Lung function testing in chronic obstructive pulmonary disease[J]. Clinics In Chest Medicine, 2020, 41(3): 347-366. DOI: 10.1016/j.ccm.2020.06.004.
|
[4] |
RODRIGUE C, BEAUCHESNE MF, Mallette V, et al. Characterization of asthma-chronic obstructive pulmonary disease overlap syndrome: A qualitative analysis[J]. COPD Journal of Chronic Obstructive Pulmonary Disease, 2017, 14(3): 330-338. DOI: 10.1080/15412555.2017.1318841.
|
[5] |
CHUNG MH, GIL BM, KWON SS, et al. Computed tomographic thoracic morphologic indices in normal subjects and patients with chronic obstructive pulmonary disease: Comparison with spiral CT densitometry and pulmonary function tests[J]. Europen Journal Of Radiology, 2018, 100: 147-153. DOI: 10.1016/j.ejrad.2018.01.014.
|
[6] |
CHEN H, CHEN RC, GUAN YB, et al. Correlation of pulmonary function indexes determined by low-dose MDCT with spirometric pulmonary function tests in patients with chronic obstructive pulmonary disease[J]. American Journal of Roentgenology, 2014, 202(4): 711-718. DOI: 10.2214/AJR.12.10501.
|
[7] |
AGUSTI A, CELLI B R, CRINER G J, et al. Global Initiative for chronic obstructive lung disease 2023 report: GOLD executive summary[J]. The European Respiratory Journal, 2023, 61(4): 2300239. DOI: 10.1183/13993003.00239-2023.
|
[8] |
KARAKAS H M, YILDIRIM G, ÇICEK E D, et al. The reliability of low-dose chest CT for the initial imaging of COVID-19: comparison of structured findings, categorical diagnoses and dose levels[J]. Diagnostic and Interventional Radiology, 2021, 27(5): 607-614. DOI: 10.5152/dir.2021.20802.
|
[9] |
GU S, WANG Z, SIEGFRIED J M, et al. Automated lobe-based airway labeling[J]. International Journal of Biomedical Imaging, 2012, 2012: 382806. DOI: 10.1155/2012/382806.
|
[10] |
GU S, MENG X, SCIURBA F C, et al. Bidirectional elastic image registration using B-spline affine transformation[J]. Computerized Medical Imaging and Graphics, 2014, 38(4): 306-314. DOI: 10.1016/j.compmedimag.
|
[11] |
金晨望, 梁志冉, 段海峰, 等. 基于体素的空气潴留定量测量方法的建立及初步临床应用[J]. 中华放射学杂志, 2019, 53(1): 5. DOI: 10.3760/cma.j.issn.1005-1201.2019.01.006.
JIN C W, LIANG Z R, DUAN H F, et al. Establishment and preliminary clinical application of a voxel-based quantitative measurement method for air retention[J]. Chinese Journal of Radiology, 2019, 53(1): 5. DOI: 10.3760/cma.j.issn.1005-1201.2019.01.006. (in Chinese).
|
[12] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management and prevention of Chronic pulmonary obstructive disease 2021 report[EB/OL]. (2020-11-17)[2021-01-24]. https://goldcopd.org/gold-reports/.
|
[13] |
GOLD Executive Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2020 report[EB/OL] . (2019-11-12)[2021-01-24] . https://goldcopdorg/gold-reports.
|
[14] |
GAWLITZA J, TRINKMANN F, SCHEFFEL H, et al. Time to exhale: Additional value of expiratory chest ct in chronic obstructive pulmonary disease[J]. Canadian Respiratory Journal, 2018, 2018: 9493504. DOI: 10.1155/2018/9493504.
|
[15] |
SUBRAMANIAN D R, GUPTA S, BURGGRAF D, et al. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography[J]. The European Respiratory Journal, 2016, 48(1): 92-103. DOI: 10.1183/13993003.01878-2015.
|
[16] |
YOUNG A L, BRAGMAN F J S, RANGELOV B, et al. Disease progression modeling in chronic obstructive pulmonary disease[J]. American Journal of Respiratory and Critical Care Medicine, 2020, 201(3): 294-302. DOI: 10.1164/rccm.201908-1600OC.
|
[17] |
BHATT S P, SOLER X, WANG X, et al. Association between functional small airway disease and fev1 decline in chronic obstructive pulmonary disease[J]. American Journal of Respiratory & Critical Care Medicine, 2016, 194(2): 178-184. DOI: 10.1164/rccm.201511-2219OC.
|
[18] |
KONIETZKE P, WIELPUTZ M O, WAGNER W L, et al. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval[J]. European Radiology, 2020, 30(5): 2502-2512. DOI: 10.1007/s00330-019-06577-y.
|
[19] |
YUAN C, CHANG D, LU G, et al. Genetic polymorphism and chronic obstructive pulmonary disease[J]. International Journal of Chronic Obstructive Pulmonary Disease, 2017, 12: 1385-1393. DOI: 10.2147/COPD.S134161.
|
[20] |
ZHAO J, LI M, CHEN J, et al. Smoking status and gene susceptibility play important roles in the development of chronic obstructive pulmonary disease and lung function decline: A population-based prospective study[J]. Medicine (Baltimore), 2017, 96(25): e7283. DOI: 10.1097/MD.0000000000007283.
|
[21] |
贾钦尧, 宋珊, 程耀, 等. 慢性阻塞性肺疾病患者合并肺结核的影响因素分析及其列线图预测模型的建立[J]. 中国感染与化疗杂志, 2023, 23(1): 6. DOI: 10.16718/j.1009-7708.2023.01.008.
JIA Q Y, SONG S, CHENG Y, et al. Analysis of influencing factors of pulmonary tuberculosis in patients with chronic obstructive pulmonary disease and the establishment of a nomogram prediction model[J]. Chinese Journal of Infection and Chemotherapy, 2023, 23(1): 6. DOI: 10.16718/j.1009-7708.2023.01.008. (in Chinese).
|
[22] |
DONG Y M, SUN J, LI Y X, et al. Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia[J]. Clinical Infectious Diseases, 2021, 72(4): 652-660. DOI: 10.1093/cid/ciaa963.
|
[23] |
CHARBONNIER J P, POMPE E, MOORE C, et al. Airway wall thickening on CT: Relation to smoking status and severity of COPD[J]. Respiratory Medicine, 2019, 146: 36-41. DOI: 10.1016/j.rmed.2018.11.014.
|